Nkarta (NKTX) EPS (Weighted Average and Diluted) (2021 - 2026)
Nkarta (NKTX) recorded quarterly EPS (Weighted Average and Diluted) of -$0.37 in Q1 2026, little changed quarter-over-quarter from -$0.37 in Q4 2025, and up 13.95% on a YoY basis from -$0.32 in Q1 2025.
Nkarta (NKTX) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Nkarta's EPS (Weighted Average and Diluted) history runs 6 years deep, the most recent figure standing at -$0.37 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 13.95% year-over-year to -$0.37; the TTM figure through Mar 2026 stood at -$1.34 (up 10.67% YoY), while the FY2025 annual figure was -$1.41, up 11.88% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.37 for Q1 2026 at Nkarta, roughly flat from -$0.37 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.29 in Q3 2025 to a low of -$0.79 in Q1 2022.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.5 across 5 years, with a median of -$0.52 in 2023.
- The sharpest annual moves came in 2023 and 2024: EPS (Weighted Average and Diluted) fell 11.48% in 2023, then jumped 50.0% in 2024.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.67 in 2022, then gained by 14.93% to -$0.57 in 2023, then jumped by 40.35% to -$0.34 in 2024, then fell by 8.82% to -$0.37 in 2025, then dropped by 0.0% to -$0.37 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.37 (Q1 2026), -$0.37 (Q4 2025), and -$0.29 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 0.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.61 |
| 10 | Nkarta | 210.15 Mn | 210.15 Mn | - | -0.37 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.37 |
| Dec 31, 2025 | -0.37 |
| Sep 30, 2025 | -0.29 |
| Jun 30, 2025 | -0.31 |
| Mar 31, 2025 | -0.43 |
| Dec 31, 2024 | -0.34 |
| Sep 30, 2024 | -0.39 |
| Jun 30, 2024 | -0.34 |
| Mar 31, 2024 | -0.58 |
| Dec 31, 2023 | -0.57 |
| Sep 30, 2023 | -0.52 |
| Jun 30, 2023 | -0.68 |
| Mar 31, 2023 | -0.63 |
| Dec 31, 2022 | -0.67 |
| Sep 30, 2022 | -0.58 |
| Jun 30, 2022 | -0.61 |
| Mar 31, 2022 | -0.79 |
| Dec 31, 2021 | -0.69 |
| Sep 30, 2021 | -0.68 |
| Jun 30, 2021 | -0.66 |